ULTI Ultimovacs

Ultimovacs ASA: Notice of extraordinary general meeting on 9 January 2024 - CORRECTION

Ultimovacs ASA: Notice of extraordinary general meeting on 9 January 2024 - CORRECTION



 

Oslo, 19 December 2024: Reference is made to the stock exchange notice published by Ultimovacs ASA (the "Company") on 17 December 2024 regarding the contemplated business combination between the Company and Zelluna Immunotherapy AS and the fully committed private placement and the stock exchange notice published at 07:00 CET today. In today's notice, one attachment was missing. All documents are included in this announcement,

The Company's board of directors (the "Board") hereby calls for an extraordinary general meeting on 9 January 2025 at 09:00 CET (the "EGM") to resolve upon the matters proposed by the Board in the attached EGM notice. 

The EGM will be held electronically. For participation, please log in at with the user ID and password provided. 

All documents and appendices regarding the EGM are made available at the Company's website: .

For further information, please see or contact:

Hans Vassgård Eid, Interim CEO and CFO, Ultimovacs ASA 

Email:  

Phone:



 

Attachments



EN
19/12/2024

Underlying

ULTIUltimovacs

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Ultimovacs

 PRESS RELEASE
Free
ULTI ULTIMOVACS

Ultimovacs ASA: Notice of extraordinary general meeting on 9 January 2...

Ultimovacs ASA: Notice of extraordinary general meeting on 9 January 2024 - CORRECTION   Oslo, 19 December 2024: Reference is made to the stock exchange notice published by Ultimovacs ASA (the "Company") on 17 December 2024 regarding the contemplated business combination between the Company and Zelluna Immunotherapy AS and the fully committed private placement and the stock exchange notice published at 07:00 CET today. In today's notice, one attachment was missing. All documents are included in this announcement, The Company's board of directors (the "Board") hereby calls for an extraor...

December 19, 2024 1 EN
 PRESS RELEASE
Free
ULTI ULTIMOVACS

Ultimovacs ASA: Notice of extraordinary general meeting on 9 January 2...

Ultimovacs ASA: Notice of extraordinary general meeting on 9 January 2024 Oslo, 19 December 2024: Reference is made to the stock exchange notice published by Ultimovacs ASA (the "Company") on 17 December 2024 regarding the contemplated business combination between the Company and Zelluna Immunotherapy AS and the fully committed private placement.  The Company's board of directors (the "Board") hereby calls for an extraordinary general meeting on 9 January 2025 at 09:00 CET (the "EGM") to resolve upon the matters proposed by the Board in the attached EGM notice.  The EGM will be held ele...

December 19, 2024 1 EN
Geir Hiller Holom
  • Geir Hiller Holom
Free Trial
ULTI ULTIMOVACS

Ultimovacs (No_rec, TP: NOK) - Recommendation and target price withdr...

Ultimovacs announced yesterday an agreement to combine its business with Zelluna Immunotherapy. Conditional upon the combination, Ultimovacs has received pre-commitments for a private placement raising gross proceeds of cNOK51.7m by issuance of new shares in Ultimovacs. Following the announcement, we have withdrawn our recommendation and target price.

12/18/24 December 18, 2024 1 EN
ABGSC Healthcare Research ... (+2)
  • ABGSC Healthcare Research
  • Alexander Krämer
12/18/24 December 18, 2024 1 EN
 PRESS RELEASE
Free
ULTI ULTIMOVACS

ULTI – EX. RIGHT TO PARTICIPATE IN POTENTIAL REPAIR OFFERING TODAY

ULTI – EX. RIGHT TO PARTICIPATE IN POTENTIAL REPAIR OFFERING TODAY Issuer name: Ultimovacs ASA Ex. date: 18 December 2024 Type of corporate action: Potential repair offering  Other information: Any repair offering is subject to the prior publication of a prospectus in accordance with applicable legislation. This information is published in accordance with the requirements of the Continuing Obligations. 

December 18, 2024 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch